V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002522 | 250009307 | 1.62 | 45 | null | null | 2022-05-21 | Cisplatin + Gemcitabine (D 1 & 8) | null | null | NIVOLUMAB | 101018822 |
| 250002533 | 250009310 | 1.56 | 16.9 | Palliative (P) | null | 2020-05-30 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | DOXORUBICIN | 101026923 |
| 250000744 | 250009314 | 1.87 | 74.2 | Palliative (P) | 2022-05-28 | 2022-05-28 | null | 02 | null | DOXORUBICIN | 101856875 |
| 250000823 | 250009317 | 1.21 | 0 | Curative (C) | 2020-08-04 | 2020-08-04 | Carboplatin AUC 2 - 5 | 02 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 100791807 |
| 250001131 | 250009319 | null | null | Palliative (P) | 2020-09-22 | 2020-09-22 | null | 02 | N | CARBOPLATIN + PEMETREXED | 100206432 |
| 250001208 | 250009320 | 1.78 | 88.4 | Curative (C) | 2020-02-08 | 2020-02-16 | CISPLATIN + VINORELBINE | N | null | NB HRNBL-1 COJEC IND COURSE C | 101544258 |
| 250001331 | 250009321 | 1.76 | 59.1 | Curative (C) | null | 2022-03-31 | MITOTANE | 02 | null | IPILIMUMAB + NIVOLUMAB | 100604720 |
| 250001358 | 250009322 | 1.66 | null | Palliative (P) | 2019-01-02 | 2020-01-30 | null | 02 | N | SUNITINIB | 100992873 |
| 250002275 | 250009326 | 1.94 | 85.3 | null | 2019-09-07 | 2019-10-21 | Atezolizumab | 02 | N | IVA | 100548739 |
| 250002107 | 250009340 | 1.66 | 61.3 | null | null | 2019-07-12 | NIVOLUMAB | null | null | NIVOLUMAB | 100626278 |
| 250002254 | 250009341 | 1.81 | 53.3 | Palliative (P) | null | 2020-09-04 | null | null | null | CISPLATIN + GEMCITABINE | 100575057 |
| 250002279 | 250009342 | 1.85 | 82.7 | null | null | 2020-06-04 | null | null | null | CARBOPLATIN + GEMCITABINE | 101420799 |
| 250002294 | 250009343 | 1.7 | 85.6 | null | null | 2018-12-13 | GemCarbo Days 1+8 | null | null | CARBOPLATIN + GEMCITABINE | 101014106 |
| 250002319 | 250009345 | 1.68 | 80 | Palliative (P) | 2019-07-18 | 2019-07-31 | NIVOLUMAB | 02 | N | NIVOLUMAB | 101205298 |
| 250002487 | 250009348 | null | null | Palliative (P) | 2018-07-18 | 2018-09-15 | null | 02 | null | ATEZOLIZUMAB | 100660762 |
| 250002541 | 250009354 | null | null | Curative (C) | 2021-07-02 | 2021-07-13 | null | 02 | N | IMATINIB | 100870402 |
| 250000284 | 250009355 | null | 62.2 | null | 2019-11-06 | 2019-11-07 | Cisplatin | 02 | null | ENZALUTAMIDE | 101298839 |
| 250001092 | 250009359 | 0 | 63 | Neo-adjuvant (N) | null | 2020-06-24 | Atezolizumab | 02 | N | ATEZOLIZUMAB | 100809939 |
| 250001131 | 250009360 | 1.7 | 24.1 | Adjuvant (A) | null | 2020-09-25 | CARBOPLATIN + ETOPOSIDE | null | null | TIP | 100206432 |
| 250001208 | 250009361 | 1.5 | 52.4 | null | 2020-03-28 | 2020-03-29 | Carboplatin + Docetaxel | 02 | N | FLUOROURACIL + MITOMYCIN | 101544258 |
| 250001331 | 250009362 | 1.7 | 82.65 | Curative (C) | 2021-12-23 | 2022-04-28 | CABOZANTINIB | 02 | N | ATEZOLIZUMAB | 100604720 |
| 250002014 | 250009364 | 1.7 | 80.8 | Palliative (P) | 2020-10-23 | 2020-11-25 | Bevacizumab 7.5mg/kg | 02 | N | IPILIMUMAB + NIVOLUMAB | 100115437 |
| 250002460 | 250009374 | 1.88 | 65.8 | null | null | 2022-02-01 | null | null | null | PEMBROLIZUMAB | 100235580 |
| 250002525 | 250009377 | 1.86 | 92 | null | null | 2022-05-27 | PEMBROLIZUMAB | null | null | PEMBROLIZUMAB | 100606801 |
| 250002533 | 250009379 | null | null | null | null | 2020-06-23 | Cisplatin + Doxorubicin | null | null | CETUXIMAB | 101026923 |
| 250002541 | 250009380 | null | null | null | null | 2021-07-13 | CARBOPLATIN + CYCLOPHOSPHAMIDE + ETOPOSIDE | null | null | IMATINIB | 100870402 |
| 250000823 | 250009382 | 1.71 | 85.6 | null | null | 2020-10-04 | Carboplatin AUC 2 - 5 | 02 | N | NOT MATCHED | 100791807 |
| 250001092 | 250009383 | null | null | null | null | 2020-06-24 | CETUXIMAB | N | Y | CAPECITABINE + IRINOTECAN | 100809939 |
| 250001331 | 250009385 | null | null | null | 2022-04-10 | 2022-04-26 | Capecitabine (21 day) + Irinotecan | 02 | N | CETUXIMAB | 100604720 |
| 250002014 | 250009387 | null | null | null | null | 2020-11-13 | Niraparib | null | null | TRIAL UNSPECIFIED | 100115437 |
| 250002352 | 250009389 | 1.72 | 85 | null | 2020-06-11 | 2020-07-08 | Sunitinib | 02 | N | CARBOPLATIN | 100092336 |
| 250000823 | 250009399 | null | null | Curative (C) | 2020-10-30 | 2020-11-03 | null | Y | null | CARBOPLATIN + ETOPOSIDE | 100791807 |
| 250001092 | 250009400 | 1.75 | 69.7 | null | 2020-07-23 | 2020-07-23 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | CISPLATIN + FLUOROURACIL | 100809939 |
| 250001131 | 250009401 | 1.56 | 107.8 | null | null | 2020-09-25 | CARBOPLATIN + FLUOROURACIL | 02 | N | ATEZOLIZUMAB | 100206432 |
| 250001331 | 250009402 | 1.55 | 102 | null | 2022-04-18 | 2022-04-26 | PACLITAXEL | 02 | null | CAPECITABINE + OXALIPLATIN | 100604720 |
| 250002014 | 250009404 | 1.83 | 66.4 | Palliative (P) | 2020-08-19 | 2020-12-04 | Atezolizumab | 02 | null | ATEZOLIZUMAB | 100115437 |
| 250001131 | 250009409 | 1.56 | 89 | Palliative (P) | 2020-10-04 | 2020-10-17 | Cisplatin + Pemetrexed | null | null | ATEZOLIZUMAB | 100206432 |
| 250002541 | 250009411 | 1.75 | 58 | Neo-adjuvant (N) | 2021-07-19 | 2021-07-27 | null | 02 | null | NIVOLUMAB | 100870402 |
| 250001092 | 250009412 | 1.83 | 94.1 | null | null | 2020-07-15 | Atezolizumab | 02 | null | ATEZOLIZUMAB | 100809939 |